Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 413

1.

Effect of Alzheimer Familial Chromosomal Mutations on the Amyloid Fibril Interaction with Different PET Tracers- Insight from Molecular Modeling Studies.

Balamurugan K, Murugan NA, Långström B, Nordberg A, Ågren H.

ACS Chem Neurosci. 2017 Sep 12. doi: 10.1021/acschemneuro.7b00215. [Epub ahead of print]

PMID:
28898051
2.

Experimental power of laboratory-scale results and transferability to full-scale anaerobic digestion.

Lüdtke M, Nordberg Å, Baresel C.

Water Sci Technol. 2017 Aug;76(3-4):983-991. doi: 10.2166/wst.2017.290.

PMID:
28799944
3.

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers.

Frisoni GB, Boccardi M, Barkhof F, Blennow K, Cappa S, Chiotis K, Démonet JF, Garibotto V, Giannakopoulos P, Gietl A, Hansson O, Herholz K, Jack CR Jr, Nobili F, Nordberg A, Snyder HM, Ten Kate M, Varrone A, Albanese E, Becker S, Bossuyt P, Carrillo MC, Cerami C, Dubois B, Gallo V, Giacobini E, Gold G, Hurst S, Lönneborg A, Lovblad KO, Mattsson N, Molinuevo JL, Monsch AU, Mosimann U, Padovani A, Picco A, Porteri C, Ratib O, Saint-Aubert L, Scerri C, Scheltens P, Schott JM, Sonni I, Teipel S, Vineis P, Visser PJ, Yasui Y, Winblad B.

Lancet Neurol. 2017 Aug;16(8):661-676. doi: 10.1016/S1474-4422(17)30159-X. Epub 2017 Jul 11. Review.

PMID:
28721928
4.

A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.

Iaccarino L, Chiotis K, Alongi P, Almkvist O, Wall A, Cerami C, Bettinardi V, Gianolli L, Nordberg A, Perani D.

J Alzheimers Dis. 2017;59(2):603-614. doi: 10.3233/JAD-170158.

PMID:
28671117
5.

Quantitative positron emission tomography in brain research.

Heurling K, Leuzy A, Jonasson M, Frick A, Zimmer ER, Nordberg A, Lubberink M.

Brain Res. 2017 Sep 1;1670:220-234. doi: 10.1016/j.brainres.2017.06.022. Epub 2017 Jun 23. Review.

PMID:
28652218
6.

Accidental copper sulfate toxicity after flame colorant ingestion.

Griswold MK, Nordberg A, Babu KM, Boyer EW, Chai PR.

Clin Toxicol (Phila). 2017 Sep;55(8):943-945. doi: 10.1080/15563650.2017.1330958. Epub 2017 Jun 8. No abstract available.

PMID:
28594239
7.

Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.

Chiotis K, Saint-Aubert L, Rodriguez-Vieitez E, Leuzy A, Almkvist O, Savitcheva I, Jonasson M, Lubberink M, Wall A, Antoni G, Nordberg A.

Mol Psychiatry. 2017 May 16. doi: 10.1038/mp.2017.108. [Epub ahead of print]

PMID:
28507319
8.

Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by 3H-THK5117 and 3H-deprenyl autoradiography.

Lemoine L, Saint-Aubert L, Nennesmo I, Gillberg PG, Nordberg A.

Sci Rep. 2017 Apr 4;7:45496. doi: 10.1038/srep45496.

9.

Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment.

Herukka SK, Simonsen AH, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger MG, Kulczyńska A, Molinuevo JL, Mroczko B, Nordberg A, Oliveira CR, Otto M, Rinne JO, Rot U, Saka E, Soininen H, Struyfs H, Suardi S, Visser PJ, Winblad B, Zetterberg H, Waldemar G.

Alzheimers Dement. 2017 Mar;13(3):285-295. doi: 10.1016/j.jalz.2016.09.009. Epub 2016 Oct 27.

10.

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia.

Simonsen AH, Herukka SK, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger MG, Kulczyńska A, Molinuevo JL, Mroczko B, Nordberg A, Oliveira CR, Otto M, Rinne JO, Rot U, Saka E, Soininen H, Struyfs H, Suardi S, Visser PJ, Winblad B, Zetterberg H, Waldemar G.

Alzheimers Dement. 2017 Mar;13(3):274-284. doi: 10.1016/j.jalz.2016.09.008. Epub 2016 Oct 27.

11.

Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.

Chiotis K, Saint-Aubert L, Boccardi M, Gietl A, Picco A, Varrone A, Garibotto V, Herholz K, Nobili F, Nordberg A; Geneva Task Force for the Roadmap of Alzheimer's Biomarkers.

Neurobiol Aging. 2017 Apr;52:214-227. doi: 10.1016/j.neurobiolaging.2016.07.012. Review.

PMID:
28317650
12.

Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.

Garibotto V, Herholz K, Boccardi M, Picco A, Varrone A, Nordberg A, Nobili F, Ratib O; Geneva Task Force for the Roadmap of Alzheimer's Biomarkers.

Neurobiol Aging. 2017 Apr;52:183-195. doi: 10.1016/j.neurobiolaging.2016.03.033. Review.

PMID:
28317648
13.

Tau PET imaging: present and future directions.

Saint-Aubert L, Lemoine L, Chiotis K, Leuzy A, Rodriguez-Vieitez E, Nordberg A.

Mol Neurodegener. 2017 Feb 20;12(1):19. doi: 10.1186/s13024-017-0162-3. Review.

14.

Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.

Ono M, Sahara N, Kumata K, Ji B, Ni R, Koga S, Dickson DW, Trojanowski JQ, Lee VM, Yoshida M, Hozumi I, Yoshiyama Y, van Swieten JC, Nordberg A, Suhara T, Zhang MR, Higuchi M.

Brain. 2017 Mar 1;140(3):764-780. doi: 10.1093/brain/aww339.

PMID:
28087578
15.

Assessment of Novel Routes of Biomethane Utilization in a Life Cycle Perspective.

Moghaddam EA, Ahlgren S, Nordberg Å.

Front Bioeng Biotechnol. 2016 Dec 19;4:89. doi: 10.3389/fbioe.2016.00089. eCollection 2016.

16.

Development of [11C]/[3H]THK-5351 - A potential novel carbon-11 tau imaging PET radioligand.

Stepanov V, Svedberg M, Jia Z, Krasikova R, Lemoine L, Okamura N, Furumoto S, Mitsios N, Mulder J, Långström B, Nordberg A, Halldin C.

Nucl Med Biol. 2017 Mar;46:50-53. doi: 10.1016/j.nucmedbio.2016.12.004. Epub 2016 Dec 9.

PMID:
28013122
17.

Theoretical study of the binding profile of an allosteric modulator NS-1738 with a chimera structure of the α7 nicotinic acetylcholine receptor.

Kuang G, Wang X, Halldin C, Nordberg A, Långström B, Ågren H, Tu Y.

Phys Chem Chem Phys. 2016 Oct 12;18(40):28003-28009.

PMID:
27711412
18.

Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease.

Ni R, Gillberg PG, Bogdanovic N, Viitanen M, Myllykangas L, Nennesmo I, Långström B, Nordberg A.

Alzheimers Dement. 2017 Apr;13(4):419-430. doi: 10.1016/j.jalz.2016.08.006. Epub 2016 Sep 28.

PMID:
27693181
19.

Regional tau deposition measured by [18F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer's disease.

Saint-Aubert L, Almkvist O, Chiotis K, Almeida R, Wall A, Nordberg A.

Alzheimers Res Ther. 2016 Sep 29;8(1):38.

20.

The Culprit Is in the Cave: The Core Sites Explain the Binding Profiles of Amyloid-Specific Tracers.

Murugan NA, Halldin C, Nordberg A, Långström B, Ågren H.

J Phys Chem Lett. 2016 Sep 1;7(17):3313-21. doi: 10.1021/acs.jpclett.6b01586. Epub 2016 Aug 12.

PMID:
27498616

Supplemental Content

Loading ...
Support Center